John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
free access
JAMA Ophthalmol. 2016;134(2):127-134. doi:10.1001/jamaophthalmol.2015.4599
This study uses data from a trial comparing bevacizumab, aflibercept, and ranibizumab for treatment of diabetic macular edema to report exploratory outcomes by baseline visual acuity and central subfield thickness subgroups.
Writing Team for the DCCT/EDIC Research Group
free access
JAMA Ophthalmol. 2016;134(2):137-145. doi:10.1001/jamaophthalmol.2015.4606
This cohort study of participants from a randomized clinical trial assesses the effects of prior intensive insulin treatment for patients with diabetes and risk factors on patient-reported visual function.
Zachary M. Bodnar, MD; Michael Neimkin, MD; John B. Holds, MD
free access
JAMA Ophthalmol. 2016;134(2):146-150. doi:10.1001/jamaophthalmol.2015.4614
This observational study describes a software algorithm for determining the margin reflex distances 1 and 2 from facial photographs and evaluates its agreement with manual measurements.
Andrew Bastawrous, MBChB, BSc(Hons), FHEA, MRCOphth; Mario Ettore Giardini, PhD; Nigel M. Bolster, MEng; et al.
free access
JAMA Ophthalmol. 2016;134(2):151-158. doi:10.1001/jamaophthalmol.2015.4625
This diagnostic accuracy study compares the grading and quality of optic disc images taken in Kenya by an ophthalmic assistant using a desktop retinal camera vs those taken by non-clinical photographers using a smartphone-based adapter for optic disc imaging.
-
Invited Commentary
Applicability of Smartphone-Based Screening Programs
Sunir J. Garg, MD
JAMA Ophthalmol
Neil M. Bressler, MD; Rohit Varma, MD; Paul Mitchell, MD; et al.
free access
JAMA Ophthalmol. 2016;134(2):160-166. doi:10.1001/jamaophthalmol.2015.4636
This exploratory post hoc analysis of 3 randomized clinical trials suggests that 12 months after initiating ranibizumab for vision impairment, patients with diabetic macular edema not driving at initiation of treatment are more likely to report driving and have driving-eligible visual acuity of 20/40 or better in the better-seeing eye than those treated with sham or laser.
Philippe Gain, MD, PhD; Rémy Jullienne, MD; Zhiguo He, PhD; et al.
free access
JAMA Ophthalmol. 2016;134(2):167-173. doi:10.1001/jamaophthalmol.2015.4776
This survey assesses the worldwide supply and demand of corneal transplantation.
Maria M. Choudhary, MD; Akshay Gupta, BS; James Bena, MS; et al.
free access
has audio
JAMA Ophthalmol. 2016;134(2):174-180. doi:10.1001/jamaophthalmol.2015.4810
This cohort study evaluates the use of serial hepatic ultrasonography in detecting asymptomatic liver metastases in patients with uveal melanoma.
-
Audio Author Interview:
Hepatic Ultrasonography for Surveillance in Uveal Melanoma (JAMA Ophthalmology)
-
Invited Commentary
Is Surveillance of Uveal Melanoma Just a Screen?
Jasmine H. Francis, MD
JAMA Ophthalmol
Sebastian M. Waldstein, MD; Ana-Maria Philip, MD; Roland Leitner, PhD; et al.
free access
JAMA Ophthalmol. 2016;134(2):182-190. doi:10.1001/jamaophthalmol.2015.4948
This cohort study examines the correlations between intraretinal cystoid fluid and subretinal fluid parameters and visual acuity in patients with neovascular age-related macular degeneration.
Robert M. Kinast, MD; Kiran K. Akula, PhD; Steve L. Mansberger, MD, MPH; et al.
free access
JAMA Ophthalmol. 2016;134(2):191-195. doi:10.1001/jamaophthalmol.2015.4970
This laboratory study evaluated whether the measured concentration of mitomycin C differs from the expected concentration of 0.4 mg/mL used in ophthalmic surgery.
Tsung-Cheng Hsieh, PhD; Chu-Lin Chou, MD, PhD; Jin-Shuen Chen, MD, PhD; et al.
free access
JAMA Ophthalmol. 2016;134(2):196-203. doi:10.1001/jamaophthalmol.2015.5052
This cohort study reports on the mortality rate and subsequent prevalence of systemic vascular diseases associated with retinal vascular occlusion among patients undergoing hemodialysis in Taiwan.
O. Bennett Walton IV, MD, MBA; Robert B. Garoon, MD; Christina Y. Weng, MD, MBA; et al.
free access
JAMA Ophthalmol. 2016;134(2):204-209. doi:10.1001/jamaophthalmol.2015.5083
This cohort analysis evaluates the efficacy of an automated algorithm in interpreting screening ophthalmoscopic photographs from patients with diabetes compared with a reading center interpretation.
-
Invited Commentary
Future Promise of and Potential Pitfalls for Automated Detection of Diabetic Retinopathy
Jennifer K. Sun, MD, MPH; Jerry D. Cavallerano, OD, PhD; Paolo S. Silva, MD
JAMA Ophthalmol
Journal Club
Dana M. Blumberg, MD, MPH; Alisa J. Prager, BS; Jeffrey M. Liebmann, MD
free access
JAMA Ophthalmol. 2016;134(2):212-220. doi:10.1001/jamaophthalmol.2015.5090
This observational study uses the Medicare Current Beneficiary Survey to assess changes in prescription drug coverage and out-of-pocket spending after the implementation of Medicare Part D.
-
Invited Commentary
Effect of Medicare Part D on the Availability of Medical Treatment for Patients With Glaucoma
Gregory L. Skuta, MD; Cynthia G. Mattox, MD; Joshua D. Stein, MD, MS
JAMA Ophthalmol
Yu T. Wang, BS; Mongkol Tadarati, MD; Yulia Wolfson, MD; et al.
free access
JAMA Ophthalmol. 2016;134(2):222-228. doi:10.1001/jamaophthalmol.2015.5332
This cross-sectional study compares the prevalence of diabetic macular edema based on monocular fundus photography vs optical coherence tomography in patients with diabetic retinopathy.